179 related articles for article (PubMed ID: 19627395)
1. CCK(2) receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours.
Körner M; Waser B; Reubi JC; Miller LJ
J Cell Mol Med; 2010 Apr; 14(4):933-43. PubMed ID: 19627395
[TBL] [Abstract][Full Text] [Related]
2. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.
Quattrone A; Dewaele B; Wozniak A; Bauters M; Vanspauwen V; Floris G; Schöffski P; Chibon F; Coindre JM; Sciot R; Debiec-Rychter M
J Pathol; 2012 Dec; 228(4):565-74. PubMed ID: 22786615
[TBL] [Abstract][Full Text] [Related]
3. The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro.
Huang H; Ansorge N; Schrader H; Banasch M; Yu HG; Schmidt WE; Höcker M; Schmitz F
Regul Pept; 2007 Dec; 144(1-3):34-42. PubMed ID: 17936921
[TBL] [Abstract][Full Text] [Related]
4. Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth.
Hellmich MR; Rui XL; Hellmich HL; Fleming RY; Evers BM; Townsend CM
J Biol Chem; 2000 Oct; 275(41):32122-8. PubMed ID: 10913157
[TBL] [Abstract][Full Text] [Related]
5. Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue.
Körner MU; Hayes GM; Carrigan PE; Rehmann R; Miller LJ; Reubi JC
Mod Pathol; 2008 Apr; 21(4):387-95. PubMed ID: 18223557
[TBL] [Abstract][Full Text] [Related]
6. Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1 alpha expression and tumor growth.
Chao C; Goluszko E; Lee YT; Kolokoltsov AA; Davey RA; Uchida T; Townsend CM; Hellmich MR
Oncogene; 2007 Feb; 26(7):1013-9. PubMed ID: 16909104
[TBL] [Abstract][Full Text] [Related]
7. SRC regulates constitutive internalization and rapid resensitization of a cholecystokinin 2 receptor splice variant.
Chao C; Ives KL; Goluszko E; Kolokoltsov AA; Davey RA; Townsend CM; Hellmich MR
J Biol Chem; 2005 Sep; 280(39):33368-73. PubMed ID: 16079138
[TBL] [Abstract][Full Text] [Related]
8. CCK receptors and cancer.
Baldwin GS; Shulkes A
Curr Top Med Chem; 2007; 7(12):1232-8. PubMed ID: 17584144
[TBL] [Abstract][Full Text] [Related]
9. A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular U2AF35 and a suboptimal 3'-splicing site leading to retention of the fourth intron.
Ding WQ; Kuntz SM; Miller LJ
Cancer Res; 2002 Feb; 62(3):947-52. PubMed ID: 11830556
[TBL] [Abstract][Full Text] [Related]
10. Human gastric tissues simultaneously express the classical and alternative splicing cholecystokinin-B/gastrin receptors.
Zhou J; Chen M; Zhang Q; Hu J; Wang W
Recept Channels; 2004; 10(5-6):185-8. PubMed ID: 15989082
[TBL] [Abstract][Full Text] [Related]
11. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.
Reubi JC; Waser B
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):781-93. PubMed ID: 12707737
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Reubi JC; Schaer JC; Waser B
Cancer Res; 1997 Apr; 57(7):1377-86. PubMed ID: 9102227
[TBL] [Abstract][Full Text] [Related]
13. The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth.
Baldwin GS
J Gastroenterol Hepatol; 1995; 10(2):215-32. PubMed ID: 7787172
[TBL] [Abstract][Full Text] [Related]
14. Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue.
Reubi JC; Waser B; Gugger M; Friess H; Kleeff J; Kayed H; Büchler MW; Laissue JA
Gastroenterology; 2003 Jul; 125(1):98-106. PubMed ID: 12851875
[TBL] [Abstract][Full Text] [Related]
15. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
[TBL] [Abstract][Full Text] [Related]
16. Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors.
Waser B; Rehmann R; Sanchez C; Fourmy D; Reubi JC
J Clin Endocrinol Metab; 2012 Feb; 97(2):482-8. PubMed ID: 22112810
[TBL] [Abstract][Full Text] [Related]
17. Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells.
Schmitz F; Schrader H; Otte J; Schmitz H; Stüber E; Herzig K; Schmidt WE
Regul Pept; 2001 Sep; 101(1-3):25-33. PubMed ID: 11495676
[TBL] [Abstract][Full Text] [Related]
18. Multiple intron retention occurs in tumor cell CD44 mRNA processing.
Goodison S; Yoshida K; Churchman M; Tarin D
Am J Pathol; 1998 Oct; 153(4):1221-8. PubMed ID: 9777953
[TBL] [Abstract][Full Text] [Related]
19. CCK-B/gastrin receptors in human colorectal cancer.
Schmitz F; Otte JM; Stechele HU; Reimann B; Banasiewicz T; Fölsch UR; Schmidt WE; Herzig KH
Eur J Clin Invest; 2001 Sep; 31(9):812-20. PubMed ID: 11589724
[TBL] [Abstract][Full Text] [Related]
20. An intron 9 containing splice variant of PAX2.
Busse A; Rietz A; Schwartz S; Thiel E; Keilholz U
J Transl Med; 2009 May; 7():36. PubMed ID: 19467152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
